AGIOS PHARMACEUTICALS, INC. Earnings Per Share Diluted

Quick Answer

AGIOS PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $7.12 (loss) per share for the year ending 2025.

  • AGIOS PHARMACEUTICALS, INC. showed a decrease of -161.2% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from AGIOS PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), AGIOS PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has declined by 3.8%.
  • Historical annual values: Fiscal year 2025: $7.12 (loss) per share | Fiscal year 2024: $11.64 per share | Fiscal year 2023: $6.33 (loss) per share | Fiscal year 2022: $4.23 (loss) per share | Fiscal year 2021: $26.55 per share | Fiscal year 2020: $4.74 (loss) per share | Fiscal year 2019: $6.86 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: